Given that our study only examined global biofluid measures of AD (plasma and CSF measures of pTau181), we are unable to address whether differences in neural selectivity relate to focal tau within the medial temporal lobe and/or cortical regions important for category-specific effects. Here, MAPT is linked to Alzheimer disease.